OakChart

Nature's Sunshine Products Inc

NATRConsumer Defensive·Packaged Foods·USA·Micro·NASD·Nov 12 • 3:59 PM ET

10.28-0.03 (-0.29%)
2026-11-13 13:11 CET
Market cap
$178.14M
Revenue, TTM
480.29 USD m
Net income, TTM
14.65 USD m
Free cash flow, TTM
10.51 USD m
EPS diluted, TTM
0.81
Price / earnings
12.64
Compare

Price

NATR against its 20, 50 and 200-day averages
Terms2050200Miss
Patternshover a marker to name it
RS 0Sales 110Price11012610.0015.0020.0025.00798K1.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NATRclose 10.2820-day 11.8550-day 12.54200-day 19.9710.2852w low 9.3852-week range, not 6 months

63.5% under the 52-week high of 28.14 on 2 Mar 2026. 52-week low 9.38 on 5 Nov 2026. Last 15 sessions, 38.0% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 0
CANSLIM 1 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%; Average Volume: Over 200K
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1)
Value 2 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 2 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 1 of 4 — fails: Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K

Profile

NATR
52-week range, 5% of the way up
9.3828.14

Nature's Sunshine Products, Inc. engages in the manufacture and sale of nutritional and personal care products. Its product lines include general health, immune, cardiovascular, digestive, personal care, and weight management. It operates through the following geographical segments: Asia, Europe, North America, and Latin America and Other. The company was founded by Eugene L. Hughes, Kristine F. Hughes, and Pauline Hughes-Francis in 1972 and is headquartered in Lehi, UT.

IndexRUT
Employees806
IPOMar 17, 1980
Beta0.83
ATR, 14d0.64
Rel volume0.00
Short float6.53%
Insider own6.16%
Inst own96.87%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$178.14M
Enterprise Value109.79M
Income14.65M
Sales480.29M
Book / share9.87
Cash / share5.16
Dividend Est.-
Dividend TTM-
Dividend Ex-DateMar 26, 2021
Dividend Gr. 3/5Y- -
Payout0.00%
Employees806
IPOMar 17, 1980

Ratios

Price / earnings12.64
Forward price / earnings10.88
Price / earnings / growth-
Price / sales0.37
Price / book1.04
Price / cash1.99
Price / free cash flow16.95
Value / cash profit2.84
Value / sales0.23
Quick Ratio1.59
Current Ratio2.56
Debt / equity0.12
Long-term debt / equity0.10
Options and shortYes / Yes

Earnings

Earnings / share0.81
Earnings next year0.94
Earnings next quarter0.13
Earnings this year-38.10%
Earnings next year21.15%
Earnings growth, 5 years-8.98%
Past earnings growth- -0.22%
Past sales growth4.40% 4.50%
Earnings vs last year0.20%
Sales vs last year1.21%
Earnings vs last quarter-64.23%
Sales vs last quarter-9.14%
EarningsNov 04 AMC
Surprise-44.00% -9.97%

Ownership

Insiders own6.16%
Insider trades64.20%
Institutions own96.87%
Institution trades5.07%
Return on assets5.50%
Return on equity8.82%
Return on capital7.79%
Gross Margin70.34%
Operating margin5.34%
Profit Margin3.05%
20-day average-13.23%
50-day average-18.01%
200-day average-48.53%

Technical

Shares out17.39M
Shares floating16.26M
Short / float6.53%
Short ratio6.18
Short interest1.06M
52-week high28.14 -63.5%
52-week low9.38 +9.6%
Volatility6.34% 4.66%
Average range0.64
Strength index31.03
Market sensitivity0.83
Relative volume0.00
Avg Volume171.64K
Volume0

Performance

Perf Week0.19%
Perf Month-18.48%
Perf Quarter-32.01%
Perf Half Y-53.86%
Perf YTD-52.36%
Perf Year-50.31%
Perf 3Y-39.53%
Perf 5Y-43.24%
Perf 10Y-23.56%
Recommendation1.00
Target Price16.50
Prev Close10.28
Price10.28
Change %0.00%

Analyst ratings

latest 6 of 6
DateActionAnalystRating changeTargetImplied
May 07, 2025ResumedDA DavidsonBuy$19+84.8%
Sep 13, 2024InitiatedCanaccord GenuityBuy$18+75.1%
Oct 15, 2021InitiatedDA DavidsonBuy$22+114.0%
Apr 09, 2015InitiatedImperial CapitalIn-line$15+45.9%
Jun 02, 2014InitiatedSingular ResearchBuy$20+94.6%
Mar 08, 2013ReiteratedImperial CapitalIn-line$17 → $15+45.9%

Peers

Mkt cap
TickerCompanyMkt cap
USNAUsana Health Sciences Inc235.21M
HLFHerbalife Ltd1.60B
LFVNLifevantage Corp63.92M
NUSNu Skin Enterprises Inc194.23M
NAIINatural Alternatives International Inc5.96M
MTEXMannatech Inc17.33M
SMPLSimply Good Foods Co1.10B
MEDMedifast Inc143.81M
NHTCNatural Health Trends Corp7.47M
HLNHaleon plc ADR39.90B

Insider trading

latest 14 of 34
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
PRESCOTT GROUP CAPITAL MANAGEM10% OwnerNov 05 '26Buy9.77291,6662,849,8112,236,152Nov 09 05:21 PM
Yates Bryant JEVP & President, EuropeNov 04 '26Option Exercise0.002,804079,897Nov 06 07:27 PM
Norman Daniel CEVP & President, AsiaNov 04 '26Option Exercise0.002,804049,727Nov 06 07:27 PM
Brower Nathan GEVP, General CounselNov 04 '26Option Exercise0.002,308045,455Nov 06 07:27 PM
Lanoy Jonathan DavidSVP, Chief Accounting OfficerNov 04 '26Option Exercise0.001,277056,812Nov 06 07:26 PM
PRESCOTT GROUP CAPITAL MANAGEM10% OwnerAug 17 '26Buy14.6920,000293,8001,944,486Aug 19 04:42 PM
PRESCOTT GROUP CAPITAL MANAGEM10% OwnerAug 07 '26Buy16.6396,0001,596,5801,883,610Aug 10 07:15 PM
PRESCOTT GROUP CAPITAL MANAGEM10% OwnerAug 10 '26Buy15.8440,876647,5391,924,486Aug 10 07:15 PM
PRESCOTT GROUP CAPITAL MANAGEM10% OwnerAug 06 '26Buy16.574,51374,7931,787,610Aug 10 07:15 PM
Herbert Kevin R.EVP & President, North AmericaJun 12 '26Sale20.682,00041,36448,866Jun 15 06:04 PM
Yates Bryant JEVP & President, EuropeJun 05 '26Sale19.9011,968238,16377,446Jun 11 07:28 PM
Norman Daniel CEVP & President, AsiaJun 01 '26Sale20.649,713200,47647,276Jun 03 06:44 PM
Brower Nathan GEVP, General CounselMay 21 '26Sale21.8412,015262,40843,438May 22 11:59 AM
Brower Nathan GEVP, General CounselMay 05 '26Option Exercise0.005,775046,893May 07 05:29 PM

Held by

AUM
TickerCompanyAUM
AVUVAvantis U.S. Small Cap Value ETFAUM: 33.08B
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
IWMiShares Russell 2000 Index FundAUM: 77.86B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.54B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.56B
VXFVanguard Extended Market Index ETFAUM: 30.79B
VDCVanguard Consumer Staples ETFAUM: 8.39B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.64B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 213.58M
VTWOVanguard Russell 2000 Index ETFAUM: 16.90B

News

latest 14 of 200

Quarterly earnings

2026Q3 EPS 0.140 missed 0.250, from 0.360 a year earlier. Sales 116.6 missed 129.51, from 128.34 a year earlier
EPS
0.36002024Q4 EPS 0.000 against 0.20024Q42025Q1 EPS 0.250 against 0.16525Q12025Q2 EPS 0.350 against 0.16025Q22025Q3 EPS 0.360 against 0.16025Q32025Q4 EPS 0.300 against 0.18525Q42026Q1 EPS 0.300 against 0.20526Q12026Q2 EPS 0.210 against 0.27026Q22026Q3 EPS 0.140 against 0.25026Q3
Sales, USD millions
129.5102024Q4 sales 118.21 against 109.324Q42025Q1 sales 113.25 against 109.325Q12025Q2 sales 114.75 against 112.2525Q22025Q3 sales 128.34 against 120.325Q32025Q4 sales 123.81 against 121.525Q42026Q1 sales 122.89 against 122.1526Q12026Q2 sales 116.99 against 123.726Q22026Q3 sales 116.6 against 129.5126Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-11-04 16:300.1400.2500.110116.6129.51EPS -44.0% · sales -10.0%vs 2025Q3, year-ago quarter · EPS -61.1% · sales -9.1%2Open -23.68% vs SPY -0.17%. Close -20.09% vs SPY -4.41%
2026Q2ended 2026-06-302026-08-06 16:300.2100.2700.193116.99123.7EPS -22.2% · sales -5.4%vs 2025Q2, year-ago quarter · EPS -40.0% · sales +1.9%2Open -15.39% vs SPY +0.32%. Close -19.47% vs SPY +0.61%
2026Q1ended 2026-03-312026-05-07 16:300.3000.2050.286122.89122.15EPS +46.3% · sales +0.6%vs 2025Q1, year-ago quarter · EPS +20.0% · sales +8.5%2Open +3.91% vs SPY +0.46%. Close -1.30% vs SPY +0.83%
2025Q4ended 2025-12-312026-03-10 16:300.3000.1850.229123.81121.5EPS +62.2% · sales +1.9%vs 2024Q4, year-ago quarter · EPS - · sales +4.7%2Open +8.49% vs SPY +0.06%. Close -1.28% vs SPY -0.13%
2025Q3ended 2025-09-302025-11-06 16:300.3600.1600.296128.34120.3EPS +125.0% · sales +6.7%vs 2024Q3, year-ago quarter · EPS +33.3% · sales +12.0%2Open +19.23% vs SPY -0.36%. Close +30.52% vs SPY +0.10%
2025Q2ended 2025-06-302025-07-31 16:300.3500.1600.281114.75112.25EPS +118.8% · sales +2.2%vs 2024Q2, year-ago quarter · EPS +400.0% · sales +3.8%2Open +10.78% vs SPY -0.91%. Close +12.78% vs SPY -1.64%
2025Q1ended 2025-03-312025-05-06 16:300.2500.1650.252113.25109.3EPS +51.5% · sales +3.6%vs 2024Q1, year-ago quarter · EPS +108.3% · sales +2.0%2Open +14.99% vs SPY +0.24%. Close +6.77% vs SPY +0.42%
2024Q4ended 2024-12-312025-03-11 16:300.0000.200-0.017118.21109.3EPS -100.0% · sales +8.1%vs 2023Q4, year-ago quarter · EPS -100.0% · sales +8.5%2Open -1.66% vs SPY +1.12%. Close -6.76% vs SPY +0.53%
2024Q3ended 2024-09-302024-11-07 16:300.2700.1420.230114.62108.94EPS +90.8% · sales +5.2%vs 2023Q3, year-ago quarter · EPS +80.0% · sales +3.1%2Open +2.31% vs SPY +0.09%. Close +7.50% vs SPY +0.43%
2024Q2ended 2024-06-302024-08-08 16:300.0700.1800.071110.55112.3EPS -61.1% · sales -1.6%vs 2023Q2, year-ago quarter · EPS -41.7% · sales -5.1%1Open -6.45% vs SPY -0.16%. Close -13.85% vs SPY +0.44%
2024Q1ended 2024-03-312024-05-07 16:300.1200.1700.121111111.2EPS -29.4% · sales -0.2%vs 2023Q1, year-ago quarter · EPS -47.8% · sales +2.2%1Open -9.99% vs SPY -0.36%. Close -17.57% vs SPY +0.01%
2023Q4ended 2023-12-312024-03-12 16:300.4500.1500.462108.94111.1EPS +200.0% · sales -1.9%vs 2022Q4, year-ago quarter · EPS +350.0% · sales +6.0%1Open +7.09% vs SPY +0.06%. Close +15.64% vs SPY -0.16%
2023Q3ended 2023-09-302023-11-07 16:300.1500.1300.145111.2110.2EPS +15.4% · sales +0.9%vs 2022Q3, year-ago quarter · EPS -350.0% · sales +6.4%1-
2023Q2ended 2023-06-302023-08-09 16:300.1200.0300.123116.55103.5EPS +300.0% · sales +12.6%vs 2022Q2, year-ago quarter · EPS +300.0% · sales +11.9%1-
2023Q1ended 2023-03-312023-05-09 16:300.230-0.0100.044108.63101.52EPS -2400.0% · sales +7.0%vs 2022Q1, year-ago quarter · EPS -866.7% · sales -1.7%1-
2022Q4ended 2022-12-312023-03-15 16:300.100-0.0400.101102.75100.3EPS -350.0% · sales +2.4%vs 2021Q4, year-ago quarter · EPS -85.3% · sales -12.9%1-

Annual earnings

2025FY EPS 1.260 beat 1.150, from 0.460 a year earlier. Sales 480.14 beat 477.82, from 454.36 a year earlier
EPS
1.4100-0.1002018FY EPS 0.19020182019FY EPS 0.34020192020FY EPS 1.07020202021FY EPS 1.410 against 0.82020212022FY EPS 0.040 against -0.10020222023FY EPS 0.950 against 0.65020232024FY EPS 0.460 against 0.66120242025FY EPS 1.260 against 1.1502025
Sales, USD millions
480.1402013FY sales 378.120132014FY sales 366.37 against 382.6320142015FY sales 324.7120152021FY sales 444.08 against 435.520212022FY sales 421.91 against 419.420222023FY sales 445.32 against 447.520232024FY sales 454.36 against 445.4820242025FY sales 480.14 against 477.822025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2028FYestimate-0.950--488.210.82
2027FYestimate-0.945--479.0510.88
2026FYestimate-0.780--466.9313.18
2025FY1.2601.1501.060480.14477.8217.13
2024FY0.4600.6610.403454.36445.4831.87
2023FY0.9500.6500.775445.32447.518.20
2022FY0.040-0.100-0.020421.91419.4208.00
2021FY1.4100.8201.419444.08435.513.12
2020FY1.070-1.069--13.23
2019FY0.340-0.344--24.87
2018FY0.190--0.045--40.58
2016FY0.110-0.110--129.15
2015FY0.660-0.698324.71-15.58
2014FY1.1200.9450.560366.37382.639.18
2013FY1.0701.2801.070378.1-9.61
2012FY1.5901.7501.590367.47370.16.47
2011FY1.1201.3901.120367.81-9.18

Quarterly results

2026Q3 revenue 116.6, from 128.34 a year earlier. Operating margin 4.5%, from 7.0% a year earlier
Revenue, USD millions
128.3402024Q4 revenue 118.224Q42025Q1 revenue 113.2525Q12025Q2 revenue 114.7525Q22025Q3 revenue 128.3425Q32025Q4 revenue 123.8125Q42026Q1 revenue 122.8926Q12026Q2 revenue 116.9826Q22026Q3 revenue 116.626Q3
Operating margin
7.802024Q4 operating margin 3.8%24Q42025Q1 operating margin 5.4%25Q12025Q2 operating margin 3.7%25Q22025Q3 operating margin 7.0%25Q32025Q4 operating margin 4.3%25Q42026Q1 operating margin 7.8%26Q12026Q2 operating margin 4.7%26Q22026Q3 operating margin 4.5%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E 0.78 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-050.78-26.2%
2026Q4Eper share2026-11-050.13-52.7%
2026FYRper share2026-11-050.74-29.3%
2026Q4Rper share2026-11-050.13-52.7%
2026FYS-2026-11-05466.93-5.8%
2026Q4S-2026-11-05110.49-12.5%
2026Q3Eper share2026-10-290.25+0.0%
2026Q3S-2026-10-29129.51+0.0%
2026Q3Rper share2026-10-280.25-5.7%
2026Q2Eper share2026-07-290.27+0.9%
2026Q2S-2026-07-29123.690.0%
2026Q2Rper share2026-07-220.270.0%
2026Q1Eper share2026-05-010.21-8.9%
2026Q1Rper share2026-05-010.21-8.9%
2026Q1S-2026-05-01122.15-0.5%
2025FYEper share2026-03-091.15-0.2%
2025Q4Eper share2026-03-090.19-3.5%
2025FYRper share2026-03-091.09-0.5%
2025Q4Rper share2026-03-090.19-2.6%
2025FYS-2026-03-09477.820.0%
2025Q4S-2026-03-09121.5-0.1%
2025Q3Eper share2025-11-030.16+1.1%
2025Q3S-2025-11-03120.30.0%
2025Q3Rper share2025-10-200.16-11.1%
2025Q2Eper share2025-07-290.16-4.1%
2025Q2Rper share2025-07-290.16-3.0%
2025Q2S-2025-07-29112.25-0.7%
2025Q1Eper share2025-05-020.170.0%
2025Q1S-2025-05-02109.3-0.1%
2025Q1Rper share2025-03-120.17-10.8%
2024FYEper share2025-03-070.66+0.1%
2024Q4Eper share2025-03-070.20+0.4%
2024FYS-2025-03-07445.480.0%
2024Q4S-2025-03-07109.3-0.1%
2024FYRper share2025-01-220.640.0%
2024Q4Rper share2025-01-220.200.0%
2024Q3Eper share2024-10-230.140.0%
2024Q3Rper share2024-10-230.140.0%
2024Q3S-2024-10-23108.940.0%
2024Q2Eper share2024-07-220.180.0%
2024Q2Rper share2024-07-220.180.0%
2024Q2S-2024-07-22112.30.0%
2024Q1Eper share2024-03-130.17-15.0%
2024Q1Rper share2024-03-130.17-15.0%
2024Q1S-2024-03-13111.2-0.6%
2023FYEper share2024-01-230.650.0%
2023FYRper share2024-01-230.470.0%
2023FYS-2023-11-09447.5-0.1%

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share-0.69-0.0450.3441.0691.419-0.020.7750.4031.0570.8133-
Sales USD millions342365362385444422445454480480-
Shares million shares191919202019191818-17
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share0.23-0.0170.2520.2810.2960.2290.2860.1930.106
Sales USD millions115118113115128124123117117
Shares million shares181818181818181817

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue480.29480.14+5.7%454.36+2.0%445.32+5.5%421.91-5.0%444.08+15.3%385.20+6.3%362.21-0.7%364.81
Cost of Goods Sold Incl. D&A142.44146.26+1.6%143.90+5.8%136.01+2.1%133.18+5.2%126.63+13.0%112.02+19.2%93.94-1.8%95.69
Gross Profit337.85333.88+7.5%310.47+0.4%309.31+7.1%288.74-9.0%317.45+16.2%273.19+1.8%268.27-0.3%269.12
Selling, General and Administrative Excl. Other312.22309.14+6.5%290.37+1.9%284.86+4.5%272.48-3.5%282.37+12.5%250.90+0.5%249.75-4.8%262.27
Research and Development-1.90+11.8%1.70+6.3%1.60+6.7%1.50+7.1%1.40-6.7%1.50-28.6%2.10-25.0%2.80
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income25.6324.74+23.1%20.09-17.8%24.45+50.4%16.26-53.7%35.09+57.4%22.29+20.4%18.52+170.4%6.85
Interest Expense0.140.10-33.3%0.15+114.3%0.07-72.0%0.250.0%0.25+150.0%0.10+150.0%0.04-89.7%0.39
Unusual Expense0.000.000.00-100.0%5.700.00-100.0%0.42-48.1%0.81-66.3%2.40+60.0%1.50
Net Income Before Taxes24.3829.81+61.7%18.43-8.8%20.20+32.8%15.21-52.2%31.82+39.4%22.82+45.9%15.64+388.8%3.20
Income Taxes9.329.36-11.1%10.53+177.8%3.79-74.1%14.66+810.6%1.61-0.14-101.6%8.71+98.0%4.40
Consolidated Net Income15.0620.45+159.2%7.89-51.9%16.42+2885.5%0.55-98.2%30.21+31.6%22.96+231.3%6.93-1.20
Net Income From Continuing Operations14.6519.52+153.5%7.70-48.9%15.08-0.39-101.4%28.85+35.2%21.34+215.7%6.76-0.85
Net Income14.6519.52+153.5%7.70-48.9%15.08-0.39-101.4%28.85+35.2%21.34+215.7%6.76-0.85
EPS (Recurring) per share0.821.06+165.0%0.40-59.2%0.98-0.02-101.4%1.43+30.0%1.10+155.8%0.43+4200.0%0.01
EPS (Basic, Before Extraordinaries) per share0.831.08+163.4%0.41-48.1%0.79-0.02-101.4%1.45+33.0%1.09+211.4%0.35-0.04
EPS (Diluted) per share0.811.06+165.0%0.40-48.1%0.77-0.02-101.4%1.42+32.7%1.07+214.7%0.34-0.04
EBITDA38.6738.59+12.5%34.31-5.4%36.27+13.6%31.94-38.1%51.60+36.6%37.77+9.4%34.52+106.1%16.75
Non-Operating Income (Expense)-1.115.17-1.52-200.0%1.52-0.79-2.60-280.6%1.44-0.44-1.76
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.644.57+20.9%3.78-2.3%3.87+69.0%2.29-15.8%2.72-1.4%2.76+78.1%1.55+3.3%1.50
Price To Earnings Ratio ratio statement ratio, not the snapshot12.6412.6416.5941.8215.1712.9913.1724.53-
Price To Sales Ratio ratio0.470.830.620.760.380.850.770.480.43
Gross Margin %70.3469.5468.3369.4668.4471.4970.9274.0773.77
Operating Margin %5.345.154.425.493.857.905.795.111.88
Net Margin %3.054.071.693.39-0.096.505.541.87-0.23
Shares Outstanding million shares17.3917.51-5.2%18.48-2.1%18.88-1.1%19.09-3.2%19.72+0.1%19.70+1.5%19.41+1.1%19.20
Market Capitalization178.14178.14-34.2%270.85-17.9%329.81+106.8%159.47-56.4%365.57+31.3%278.33+70.2%163.49+10.3%148.23

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue116.60-9.1%116.98+1.9%122.89+8.5%123.81+4.7%128.34+12.0%114.75+3.8%113.25+2.0%118.20+8.5%
Cost of Goods Sold Incl. D&A34.85-7.9%34.11-5.1%36.14+2.8%37.33+0.5%37.83+4.0%35.95+2.2%35.15-0.1%37.16+10.4%
Gross Profit81.75-9.7%82.87+5.2%86.75+11.1%86.47+6.7%90.51+15.7%78.80+4.5%78.10+3.0%81.04+7.7%
Selling, General and Administrative Excl. Other76.47-6.2%77.39+3.8%77.21+7.3%81.15+6.1%81.53+11.8%74.53+6.9%71.93+1.0%76.49+9.8%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income5.28-41.1%5.48+28.3%9.54+54.6%5.32+16.9%8.97+69.9%4.27-24.3%6.17+33.5%4.55-18.9%
Interest Expense0.030.0%0.05+150.0%0.04+100.0%0.030.030.020.020.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes5.37-44.5%5.37-28.8%8.15+14.6%5.49+278.6%9.67+22.4%7.54+70.6%7.11+52.6%1.45-81.1%
Income Taxes3.48-15.9%1.83-9.4%3.04+36.3%0.97-55.5%4.14+27.4%2.02-31.3%2.23+2.8%2.18
Consolidated Net Income1.89-65.9%3.54-35.9%5.12+4.9%4.515.54+19.1%5.52+270.5%4.88+96.0%-0.73-107.8%
Net Income From Continuing Operations1.89-64.5%3.54-33.6%5.12+7.8%4.115.33+22.5%5.33+294.8%4.75+104.7%-0.32-103.6%
Net Income1.89-64.5%3.54-33.6%5.12+7.8%4.115.33+22.5%5.33+294.8%4.75+104.7%-0.32-103.6%
EPS (Recurring) per share0.11-63.3%0.19-32.1%0.29+16.0%0.230.30+30.4%0.28+300.0%0.25+108.3%-0.02-104.3%
EPS (Basic, Before Extraordinaries) per share0.11-63.3%0.20-31.0%0.29+11.5%0.230.30+30.4%0.29+314.3%0.26+116.7%-0.02-104.3%
EPS (Diluted) per share0.11-63.3%0.19-32.1%0.29+16.0%0.230.30+30.4%0.28+300.0%0.25+108.3%-0.02-104.3%
EBITDA8.49-32.1%8.78+13.0%12.77+32.1%8.63+0.7%12.51+41.8%7.77-15.0%9.67+24.3%8.57-1.0%
Non-Operating Income (Expense)0.12-83.3%-0.06-101.8%-1.35-240.6%0.190.72-72.5%3.290.96+3100.0%-3.10-259.0%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.54+51.0%1.57+21.7%1.29+25.2%1.23+29.5%1.02+36.0%1.29+29.0%1.03-4.6%0.95+9.2%
Price To Earnings Ratio ratio statement ratio, not the snapshot12.6419.9722.6726.5920.8127.6331.0616.59
Price To Sales Ratio ratio0.470.810.880.810.590.610.520.60
Gross Margin %70.1170.8470.5969.8570.5268.6768.9668.56
Operating Margin %4.534.697.774.306.993.725.453.85
Net Margin %1.623.024.163.324.164.654.19-0.27
Shares Outstanding million shares17.39-1.0%17.61-0.2%17.56-4.9%17.51-5.2%17.56-5.1%17.64-4.7%18.47-1.7%18.48-2.1%
Market Capitalization178.14-34.9%383.35+40.4%420.01+81.1%377.56+39.4%273.70+8.6%273.07-3.3%231.97-40.7%270.85-17.9%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments93.89+10.9%84.70+2.8%82.37+37.2%60.03-30.3%86.18-6.4%92.07+71.7%53.63+5.9%50.64+18.0%42.91
Short Term Receivables8.60-9.3%9.48+7.4%8.83-37.4%14.11+59.1%8.87+20.2%7.38+0.8%7.32-5.5%7.75-12.8%8.89
Inventories68.31+14.9%59.44-11.1%66.89-1.6%67.95+11.7%60.85+27.6%47.68+2.2%46.67+11.0%42.05-4.5%44.05
Other Current Assets8.04+15.5%6.96-9.8%7.72+4.0%7.42-15.3%8.76+26.2%6.94+36.3%5.09-20.3%6.39-4.1%6.66
Total Current Assets178.84+11.4%160.58-3.2%165.82+10.9%149.51-9.2%164.67+6.9%154.06+36.7%112.70+5.5%106.83+4.2%102.51
Net Property, Plant & Equipment50.52-3.6%52.38-10.2%58.36-6.3%62.31-10.0%69.21-7.2%74.56-10.7%83.46+30.3%64.06-7.3%69.11
Total Investments and Advances1.13+22.8%0.92+22.7%0.75+7.1%0.70-27.1%0.96-3.0%0.99-13.9%1.15-12.2%1.31-33.8%1.98
Intangible Assets------0.57-8.1%0.62-12.7%0.71
Deferred Tax Assets20.07+13.8%17.64+17.1%15.06+119.5%6.86-49.5%13.59+56.4%8.69+77.3%4.90-45.9%9.06+9.4%8.28
Other Assets10.59+13.5%9.33-4.6%9.78-6.0%10.40-0.5%10.45-6.6%11.19+8.9%10.28-7.8%11.15-11.6%12.61
Total Assets261.15+8.4%240.85-3.6%249.77+8.7%229.78-11.2%258.87+3.8%249.50+17.1%213.07+10.4%193.02-1.1%195.19
Short Term Debt Incl. Current Port. of LT Debt3.27-16.8%3.93-13.6%4.55-16.4%5.44-7.8%5.90-21.3%7.50+16.1%6.46+322.2%1.53+200.0%0.51
Accounts Payable8.02-10.0%8.91+12.6%7.91+24.6%6.35-34.5%9.70+49.5%6.49+47.2%4.41-15.5%5.22+24.0%4.21
Income Tax Payable4.70+14.1%4.12-35.8%6.42+55.8%4.12+55.5%2.65+10.9%2.39+71.9%1.39-58.9%3.38+84.7%1.83
Other Current Liabilities62.54+28.3%48.74-15.8%57.88+16.5%49.68-15.0%58.42+9.6%53.28+16.6%45.69-19.2%56.56+20.1%47.10
Total Current Liabilities78.54+19.6%65.69-14.4%76.75+17.0%65.58-14.5%76.67+10.1%69.65+20.2%57.95-13.1%66.69+24.3%53.66
Long Term Debt15.63+52.0%10.28-1.0%10.38-24.5%13.74-19.6%17.09-9.2%18.83-6.8%20.210.00-100.0%13.18
Provision for Risks Charges0.73-21.5%0.93+52.5%0.61+19.6%0.51+70.0%0.30-23.1%0.39-74.0%1.50-42.1%2.59-53.2%5.53
Deferred Tax Liabilities0.95-5.9%1.01-27.9%1.40-2.8%1.44-8.3%1.57+12.9%1.39-16.3%1.66+6.4%1.56+102.6%0.77
Other Liabilities3.74+90.8%1.96+79.8%1.09-25.3%1.46-20.7%1.84-8.0%2.00-13.8%2.32+44.1%1.61-30.6%2.32
Total Liabilities99.59+24.7%79.86-11.5%90.23+9.1%82.73-15.1%97.47+5.6%92.26+10.3%83.63+15.4%72.45-4.0%75.46
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity161.55+4.0%155.31+0.8%154.06+7.8%142.91-9.7%158.20+1.8%155.39+20.3%129.21+7.2%120.50+1.0%119.32
Total Shareholders Equity161.55+4.0%155.31+0.8%154.06+7.8%142.91-9.7%158.20+1.8%155.39+20.3%129.21+7.2%120.50+1.0%119.32
Accumulated Minority Interest0.00-100.0%5.68+3.6%5.48+32.4%4.14+29.4%3.20+73.0%1.85+704.3%0.23+283.3%0.06-85.4%0.41
Total Equity161.55+0.3%160.99+0.9%159.54+8.5%147.05-8.9%161.40+2.7%157.23+21.5%129.44+7.4%120.57+0.7%119.73
Total Liabilities & Stockholders Equity261.15+8.4%240.85-3.6%249.77+8.7%229.78-11.2%258.87+3.8%249.50+17.1%213.07+10.4%193.02-1.1%195.19
Book Value Per Share per share9.23+9.9%8.40+2.9%8.16+9.1%7.48-6.7%8.02+1.6%7.89+18.5%6.66+6.2%6.27-0.6%6.31
Tangible Book Value Per Share per share9.23+9.9%8.40+2.9%8.16+9.1%7.48-6.7%8.02+1.6%7.89+19.0%6.63+6.3%6.24-0.5%6.27
Full-Time Employees people806-1.6%819+0.6%814+1.8%800-5.9%850+1.6%837+0.4%834-7.8%905-0.7%911
Price to Book Ratio ratio1.041.732.251.162.311.791.271.231.52
Return on Assets %7.783.146.29-0.1611.359.233.33-0.44-6.46
Return on Equity %12.324.9810.15-0.2618.4014.995.42-0.71-10.34
Return on Invested Capital %11.024.659.17-0.2516.4612.254.53-0.71-9.77
Quick Ratio ratio1.411.541.291.241.351.531.140.971.09
Current Ratio ratio2.282.442.162.282.152.211.941.601.91

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income15.0620.45+159.2%7.89-51.9%16.42+2885.5%0.55-98.2%30.21+31.6%22.96+231.3%6.93-1.20
Depreciation13.0413.84-2.7%14.22+20.3%11.82-24.6%15.68-5.1%16.52+6.7%15.48-3.2%15.99+63.0%9.81
Other Funds (Non Cash)13.276.39-52.0%13.31+59.6%8.34+60.7%5.19-23.1%6.75+141.9%2.79-7.9%3.03+118.0%1.39
Funds from Operations42.2138.41+13.8%33.76+20.4%28.05+0.1%28.03-43.2%49.35+33.8%36.87+22.0%30.23+202.9%9.98
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-22.57-3.09-8.46-164.2%13.18-27.32-14.74-1965.8%0.79-21.69-282.9%11.86
Income Taxes Payable-6.16-0.06-2.94-211.8%2.63+83.9%1.43-0.39-158.2%0.67-1.96-250.8%1.30
Cash from Operating Activities19.6435.32+39.6%25.30-38.6%41.23+5707.0%0.71-97.9%34.61-8.1%37.66+341.0%8.54-60.9%21.83
Capital Expenditures-9.13-6.48-10.97-10.48-7.63-6.67-4.91-5.10-4.83
Net Assets From Acquisitions-6.16-6.160.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.00-100.0%0.050.000.00-100.0%5.04
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-15.29-12.64-10.97-10.48-7.63-6.61-4.91-5.10-2528.6%0.21
Cash Dividends Paid0.000.000.000.000.00-19.860.000.000.00
Change in Capital Stock-8.03-16.31-8.86-6.40-13.57-9.66-2155.3%0.47+80.8%0.26-60.6%0.66
Repurchase of Common Pref Stock-8.03-16.31-8.86-6.40-13.57-7.420.000.000.00
Sale of Common Pref Stock0.000.000.000.000.00-2.23-574.5%0.47+80.8%0.26-60.6%0.66
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.00-1.17-1.55-2.20-164.5%3.410.00-12.18
Change in Long Term Debt0.000.000.00-1.17-1.24-1.31-5.370.00-13.18
Issuance of Long Term Debt34.205.09-87.6%40.99+151.6%16.29-63.8%45.010.000.00-100.0%2.06-97.0%68.32
Reduction of Long Term Debt-34.20-5.09-40.99-17.47-46.25-1.31-5.37-2.06-81.50
Net Financing Active Other Cash Flow-2.93-1.30-1.05-0.39-1.130.000.00-0.32-0.68
Other Financing Activities Uses-2.93-1.30-1.05-0.39-1.130.000.00-0.32-0.68
Cash from Financing Activities-10.96-17.61-9.90-7.96-16.25-31.72-917.5%3.88-0.06-12.19
Exchange Rate Effect0.444.12-2.10-0.45-2.99-2.16-219.3%1.81-0.39-2.12
Net Change in Cash-6.189.19+294.4%2.33-89.6%22.34-26.15-5.88-115.3%38.44+1185.6%2.99-61.3%7.73
Free Cash Flow10.5128.84+101.3%14.33-53.4%30.75-6.92-124.8%27.94-14.7%32.75+852.0%3.44-79.8%17.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow ratio21.5813.8219.5310.95-46.529.1151.039.17
Deferred Taxes & Investment Tax Credit--2.27-1.66-8.53-229.2%6.60-4.13-4.36-201.9%4.28-0.02

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments89.38-6.5%82.50+1.4%87.58+1.3%93.89+10.9%95.55+21.4%81.34+18.4%86.49+11.2%84.70+2.8%
Short Term Receivables18.32+21.2%13.86+6.4%12.55+10.0%8.60-9.3%15.11+32.5%13.03+15.4%11.41+17.8%9.48+7.4%
Inventories71.29+5.9%71.73+3.5%67.13+3.4%68.31+14.9%67.33+8.1%69.32+11.3%64.93+3.6%59.44-11.1%
Other Current Assets9.39+16.2%10.30+26.5%11.33+42.3%8.04+15.5%8.08-27.4%8.14-16.5%7.96-20.7%6.96-9.8%
Total Current Assets188.38+1.2%178.40+3.8%178.59+4.6%178.84+11.4%186.08+13.8%171.84+13.0%170.78+6.6%160.58-3.2%
Net Property, Plant & Equipment48.72+3.8%50.24+0.2%51.79+1.2%50.52-3.6%46.94-15.9%50.15-14.3%51.16-16.5%52.38-10.2%
Total Investments and Advances1.23+10.8%1.25+20.2%1.27+35.1%1.13+22.8%1.11+24.7%1.04+16.9%0.94+17.5%0.92+22.7%
Deferred Tax Assets19.33-5.1%19.50-8.9%19.41-3.0%20.07+13.8%20.36+36.3%21.41+45.6%20.02+31.0%17.64+17.1%
Other Assets10.57+2.4%10.440.0%10.40+6.1%10.59+13.5%10.32+1.6%10.44+8.2%9.80+0.1%9.33-4.6%
Total Assets268.23+1.3%259.82+1.9%261.46+3.5%261.15+8.4%264.81+7.9%254.88+8.1%252.70+2.2%240.85-3.6%
Short Term Debt Incl. Current Port. of LT Debt4.57-0.7%4.42-4.3%4.37+1.9%3.27-16.8%4.60+13.9%4.62+16.7%4.29-15.2%3.93-13.6%
Accounts Payable8.15+14.5%7.73-22.1%8.25-16.4%8.02-10.0%7.12-19.8%9.92+17.8%9.87+9.3%8.91+12.6%
Income Tax Payable1.58-79.2%3.50-39.2%4.97-24.0%4.70+14.1%7.60+16.6%5.76+47.3%6.54-9.3%4.12-35.8%
Other Current Liabilities59.19-8.0%53.09-4.4%53.78+7.5%62.54+28.3%64.33+34.8%55.54+17.3%50.04+5.2%48.74-15.8%
Total Current Liabilities73.49-12.1%68.75-9.4%71.37+0.9%78.54+19.6%83.65+24.6%75.85+19.2%70.74+2.7%65.69-14.4%
Long Term Debt16.46+69.9%17.00+54.4%18.06+71.0%15.63+52.0%9.69-13.8%11.01-3.3%10.56-28.5%10.28-1.0%
Provision for Risks Charges1.75+297.7%0.11-82.8%0.43-31.7%0.73-21.5%0.44-32.3%0.64-31.9%0.63+1.6%0.93+52.5%
Deferred Tax Liabilities1.070.0%0.89-11.9%0.80-31.0%0.95-5.9%1.07-20.7%1.01-12.9%1.16-23.2%1.01-27.9%
Other Liabilities3.79+16.6%3.77+40.1%3.88+54.0%3.74+90.8%3.25+39.5%2.69+17.5%2.52+41.6%1.96+79.8%
Total Liabilities96.55-1.6%90.51-0.7%94.54+10.4%99.59+24.7%98.10+18.6%91.19+14.8%85.60-2.2%79.86-11.5%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity171.68+7.0%169.32+7.4%166.92+3.5%161.55+4.0%160.50+2.5%157.68+4.7%161.28+4.7%155.31+0.8%
Total Shareholders Equity171.68+7.0%169.32+7.4%166.92+3.5%161.55+4.0%160.50+2.5%157.68+4.7%161.28+4.7%155.31+0.8%
Accumulated Minority Interest0.00-100.0%0.00-100.0%0.00-100.0%0.00-100.0%6.20+1.8%6.00+3.6%5.82+3.0%5.68+3.6%
Total Equity171.68+3.0%169.32+3.4%166.92-0.1%161.55+0.3%166.70+2.5%163.68+4.7%167.10+4.6%160.99+0.9%
Total Liabilities & Stockholders Equity268.23+1.3%259.82+1.9%261.46+3.5%261.15+8.4%264.81+7.9%254.88+8.1%252.70+2.2%240.85-3.6%
Book Value Per Share per share9.87+8.0%9.61+7.5%9.50+8.8%9.23+9.9%9.14+8.0%8.94+9.8%8.73+6.5%8.40+2.9%
Tangible Book Value Per Share per share9.87+8.0%9.61+7.5%9.50+8.8%9.23+9.9%9.14+8.0%8.94+9.8%8.73+6.5%8.40+2.9%
Full-Time Employees people---806-1.6%---819+0.6%
Price to Book Ratio ratio1.042.292.602.361.741.691.491.73
Return on Assets %5.507.037.747.785.925.754.053.14
Return on Equity %8.8211.0712.1212.329.529.156.424.98
Return on Invested Capital %1.001.902.772.323.133.162.76-0.19
Quick Ratio ratio1.591.551.561.411.421.351.501.54
Current Ratio ratio2.562.602.502.282.222.272.412.44

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income1.89-65.9%3.54-35.9%5.12+4.9%4.515.54+19.1%5.52+270.5%4.88+96.0%-0.73-107.8%
Depreciation3.21-9.3%3.30-5.7%3.22-8.0%3.31-17.7%3.540.0%3.500.0%3.50+10.8%4.02+31.8%
Other Funds (Non Cash)2.98+79.5%3.333.93+96.5%3.02-42.7%1.66+133.8%-0.29-106.0%2.00-20.9%5.27+913.5%
Funds from Operations8.45-28.5%10.14+34.7%12.95+54.2%10.67+55.3%11.81+32.3%7.53-24.2%8.40+4.7%6.87-6.9%
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital2.30-65.5%-9.31-14.80-0.77-114.5%6.66+865.2%-3.19-5.795.31+139.2%
Income Taxes Payable-1.97-199.0%-1.440.13-94.3%-2.871.99-18.1%-1.462.28+137.5%-3.12-271.4%
Cash from Operating Activities10.75-41.8%0.84-80.6%-1.85-170.9%9.90-18.7%18.47+92.0%4.34+233.8%2.61+19.2%12.18+26.9%
Capital Expenditures-1.54-2.78-2.48-2.34-1.68-1.35-1.11-2.19
Net Assets From Acquisitions0.000.000.00-6.160.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.54-2.78-2.48-8.50-1.68-1.35-1.11-2.19
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock-3.53-2.06-0.50-1.93-2.02-11.88-0.48-0.42
Repurchase of Common Pref Stock-3.53-2.06-0.50-1.93-2.02-11.88-0.48-0.42
Sale of Common Pref Stock0.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.00-100.0%0.00
Change in Long Term Debt0.000.000.000.000.000.000.00-100.0%0.00
Issuance of Long Term Debt0.0019.31+1671.6%11.62+1491.8%3.26+297.6%0.00-100.0%1.09-96.3%0.73-84.8%0.82-70.6%
Reduction of Long Term Debt0.00-19.31-11.62-3.260.00-1.09-0.73-0.82
Net Financing Active Other Cash Flow-0.03-1.39-1.08-0.43-0.37-0.24-0.26-0.15
Other Financing Activities Uses-0.03-1.39-1.08-0.43-0.37-0.24-0.26-0.15
Cash from Financing Activities-3.56-3.46-1.58-2.36-2.40-12.12-0.73-763.6%-0.58
Exchange Rate Effect1.220.32-92.0%-0.41-140.2%-0.70-0.19-106.1%3.99+187.1%1.02-3.42-232.6%
Net Change in Cash6.87-51.7%-5.08-6.31-452.5%-1.66-127.7%14.21+42.0%-5.141.796.00-5.4%
Free Cash Flow9.21-45.1%-1.94-164.9%-4.33-388.7%7.56-24.3%16.79+113.1%2.991.509.99+19.6%
Price to Free Cash Flow ratio21.5822.1018.6913.418.9512.5413.6518.91

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Cardiovascular Products81.7081.64-0.1%17.0%
Digestive Products111.74124.37+11.3%25.9%
General Health Products183.88192.12+4.5%40.0%
Immunity Products38.7240.82+5.4%8.5%
Personal Care Products17.8023.27+30.7%4.8%
Weight Management Products20.5117.93-12.6%3.7%
Total454.36480.14+5.7%100.0%
Region
Name20242025vs 20242025 share
Japan43.9456.07+27.6%11.7%
Other countries160.56172.57+7.5%35.9%
South Korea51.3650.84-1.0%10.6%
Taiwan70.5867.28-4.7%14.0%
United States127.92133.39+4.3%27.8%
Total454.36480.14+5.7%100.0%
Segment
Name20242025vs 20242025 share
Asia207.79221.78+6.7%46.2%
Europe84.8493.13+9.8%19.4%
Latin America and other22.8821.62-5.5%4.5%
North America138.85143.61+3.4%29.9%
Total454.36480.14+5.7%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.53%1.1M16.3M159.27K
2026-10-155.56%0.9M16.5M160.54K
2026-09-305.19%0.9M16.5M159.34K
2026-09-155.02%0.8M16.5M166.10K
2026-08-314.85%0.8M16.6M167.26K
2026-08-143.28%0.5M16.6M151.74K
2026-07-313.04%0.5M16.6M122.92K
2026-07-153.05%0.5M16.6M117.58K
2026-06-303.77%0.6M16.6M115.01K
2026-06-153.52%0.6M16.6M113.22K
2026-05-292.07%0.3M16.6M111.78K
2026-05-151.79%0.3M16.6M109.02K
2026-04-301.67%0.3M16.1M122.19K
2026-04-151.40%0.2M16.0M132.00K
2026-03-311.54%0.2M16.0M131.36K
2026-03-131.46%0.2M16.0M124.94K
2026-02-271.29%0.2M16.0M117.55K
2026-02-131.43%0.2M16.0M119.11K
2026-01-301.22%0.2M16.0M130.52K
2026-01-151.00%0.2M16.0M121.11K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.506.109.500.0018.8580.000.000.986-0.0180.001
call5.003.607.000.009.5710.000.000.974-0.0170.001
call7.501.054.500.005.7910.000.000.948-0.0150.002
call10.000.002.150.403.5031.000.000.580-0.0620.006
call12.500.002.600.004.8170.000.000.531-0.1840.006
call15.000.000.050.055.6412.000.000.504-0.2050.006
call17.500.002.600.001.9730.000.000.045-0.0180.001
call20.000.002.602.932.3513.000.000.039-0.0190.001
call22.500.002.600.552.6722.000.000.036-0.0200.001
call25.000.000.051.504.99619.000.000.226-0.1370.005
call30.000.000.050.763.21620.000.000.030-0.0200.001
call35.000.002.601.153.7971.000.000.027-0.0230.001
put2.500.001.750.005.2950.000.00-0.014-0.0180.001
put5.000.001.750.002.8460.000.00-0.026-0.0170.001
put7.500.000.750.001.4140.000.00-0.052-0.0140.002
put10.000.000.150.050.4481.000.00-0.401-0.0510.006
put12.500.553.901.094.3871230.00-0.469-0.1830.006
put15.003.006.403.005.3262.000.00-0.944-0.0150.002
put17.505.508.900.656.0353.000.00-0.955-0.0160.001
put20.008.0011.403.006.6033.000.00-0.961-0.0170.001
put22.5010.5013.902.307.0791.000.00-0.964-0.0180.001
put25.0013.0016.403.807.4860.000.00-0.967-0.0180.001
put30.0018.0021.405.008.1570.000.00-0.970-0.0190.001
put35.0023.0026.400.008.6960.000.00-0.973-0.0190.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-094Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-27SCHEDULE 13G/ASEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-143Initial statement of beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-10SCHEDULE 13G/ASEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-21SEC
2026-05-204Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-112.85M100
2026-100000
2026-090000
2026-082.61M400
2026-070000
2026-0600480.00K3
2026-0500262.41K1
2026-040000
2026-0300951.21K3
2026-020000
2026-010000
2025-120037.89K1
2025-1100363.09K3

Institutional holders

Manager% owned
WYNNEFIELD CAPITAL INC14.07%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.11.05%
DIMENSIONAL FUND ADVISORS LP5.72%
BlackRock, Inc.5.62%
AMERICAN CENTURY COMPANIES INC4.67%
KENNEDY CAPITAL MANAGEMENT LLC3.55%
VANGUARD CAPITAL MANAGEMENT LLC3.44%
ACADIAN ASSET MANAGEMENT LLC3.38%
RENAISSANCE TECHNOLOGIES LLC3.02%
Boston Partners2.18%

Funds

Fund% owned
Avantis U.S. Small Cap Value ETF3.89%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.40%
iShares Russell 2000 ETF2.23%
Boston Partners Small Cap Value Fund II (R6)1.07%
College Retirement Equities Fund - Total Global Stock Account1.02%
VANGUARD EXTENDED MARKET INDEX FUND0.96%
VANGUARD CONSUMER STAPLES INDEX FUND0.94%
Fidelity Small Cap Index Fund0.90%
U.S. Targeted Value Portfolio0.74%
U.S. SMALL CAP VALUE PORTFOLIO0.68%

OakChart. NATR. Cached 15 minutes. Terms